source
- Trump announces nine new drug pricing agreements to align U.S. prices with peer nationsPresident Trump announced a new round of voluntary pricing agreements with nine additional pharmaceutical companies, adding to the 17 firms that have previously signed similar deals. The companies…
- Novartis and Bristol Myers pause multiple autoimmune CAR-T trials after serious immune adverse eventsNovartis and Bristol Myers Squibb announced a temporary halt to several CAR-T cell therapy trials targeting autoimmune diseases. The pause involves Novartis’s autologous CD19 CAR-T candidate rapca…